PATENT CLAIM ANALYSIS

Application Number: 15894472
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "021910"]

Abstract:
The present invention regards specific IBAT inhibitors useful in the prophylaxis and/or treatment of a liver disease. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.

Claim (Index 2):
A method for treating a bile acid dependent disease which impacts at least the extrahepatic or intrahepatic biliary tree in a subject, the method comprising orally administering to a subject in need of such treatment a therapeutically effective amount an IBAT inhibitor, wherein the IBAT inhibitor is 1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N\u2014{(R)-\u03b1-[N\u2014((S)-1-carboxypropyl) carbamoyl]-4-hydroxybenzyl} carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 88.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15726071', '15726203', '15276446', '15069355', '15722110']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7476717654848248
- 35 USC 102 Novelty (BERT): 0.456447708337199
- Combined Prediction Score: 0.7185493597700623
- Mean Citation Score: 208.368256
- Max Citation Score: 215.07954
- Similarity Product: 198.30200067848327

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test